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A 1008 busepalr (bp) eDNA clone encoding 335 amino acids followed by an inframe TGA translation termination ¢odon 
and a 295-nacleotide Y untranslated (UT) region has been isolated from a pig liver eDNA library. Based on the deduced 
amino acid and nudeotide sequence homology to a human eDNA (Kaumeyer, J.F., Polazzi, J.O. and Kotiek, M.P. 
(1986) Nucleic Acids Res. 14, 7839-7850), the 5' amino terminus was found to code for at-miernglebulin (at-M), a 183 
amino acid protein belonging to the lipocalin protein superfamily (Pervaiz, S. and Brew, K. (1985) Science 228, 
335-337). The 3' half encoded HI-30 which constitutes the Kunitz-type proteinase inhibitory (l.,.chein) domain of 
porcine inter-alpha-trypsin inhibitor (iaTl). In Northern blot hybridization, this eDNA identified two equally almndant 
mRNA species of approx. 1.3 kb and 1.6 kb in length. However, a 125 bp eDNA probe derived from the 3" UT region of 
the eDNA hybridized only to the 1.6 kb ntRNA. The differences observed in the 3'  UT region of these mRNAs suggest 
the utilization of alternative polyadenylation signals or presence of unprocessed nuclear RNA. Deusitmnetrk scanning 
of Northern blots Indicated that a t -M/HI -30  mRNA levels were higher (5-8-fold) in fetal and neonatal liver compared 
to that of primiparm~ pigs. in contrast, the RNA levels did not change signif'gantiy dining pregnancy. Dot blot analysis 
of RNA indicated liver to be the major site of at-M/HI-30 mRNA expression with lower levels observed in the 
stomach. The results suggest that modulation of at-M/HI-30 geue expression could play a role during porcine growth. 
Increased laT!  L-chain mRNA levels may be particularly important in fetal and neonatal development when regulation 
of the inflammatory response and protection of macmmoleeoles from proteolytic degradation is vital to survival and 
sustained growth. 
Introduction 
Human inter-alpha-trypsin inhibitor (laTI) is a com- 
plex plasma protein of M r 250000 originally identified 
as protein ¢t [3]. Although thought for sometime to be a 
single chain polypeptide [4,5], laTI has now been shown 
to be composed of two non-inhibitory heavy chains 
linked to a light (L) chain proteinase inifibitory domain 
known as HI-30 [6]. Polypeptides for two heavy and the 
single light chains appear to be synthesized by three 
different mRNA species [7]. A newly identified pre-al- 
pha-trypsin inhibitor (PaTI; M, 125000) utilizes the 
common L-chain Kunitz inhibitor but contains only a 
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single heavy chain [8]. A glycosaminoglycan chain lin- 
ked to serine-10 residue of L-chain (HI-30) appears to 
be responsible for physical association of the heavy and 
light chains in both IaTI and PaTI [8]. In human, the 
intracellular precursor for the L-chain peptide is com- 
posed of two functionally unrelated proteins: (1) at-mi- 
croglobulin (HC), an acute phase reactant belonging to 
the fipocalin superfamily of plasma proteins that cir- 
culate in plasma both free and as a complex with IgA 
[9.10] and impedes antigen stimulation of lymphocytes 
[11] as well as inhibits neutrophil chemotaxis [12], and 
(2) a serine proteinase inhibitor (HI-30) which contains 
two tandem Kunitz-type domains and is responsible for 
the proteinase inhibitory activity of laTl and PaTI 
[6,81. 
Although the nucleotide sequence for the single com- 
mon L-chain of human laTl and PaTl have been 
determined by several laboratories [1,13-14], no eDNA 
clones have yet been identified from any other species. 
In an attempt to character:.~ze porcine insulin-like growth 
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factor I (IGF-I) [15], we originally employed im- 
munoscreening of a pig liver cDNA library constructed 
in a lambda gtll  expression vector. A rabbit antiserum 
raised to human IGF-I [16] identified a cross-reacting 
lambda bacteriophage clone (CLT8c) that remained an- 
tibody positive after several rounds of screening. Fur- 
ther analysis of the CLT8c phage revealed three EcoRI 
restriction fragments that did not hybridize to a 32p. 
labeled porcine IGF-I eDNA probe. We have de- 
termined the identity of these EcoRl fragments as en- 
coding portions of HI-30 and serum alb,min. The origi- 
nal eDNA isolate for laTl L-chain (HI-30) has now 
been utilized to isolate a nearly full-length eDNA clone, 
and to examine tissue specificity and temporal expres- 
sion of al-M/H!-30 mRNA during porcine develop- 
ment. Also, we provide evidence that porcine a~ M and 
HI-30, similar to that of human, are co-translated from 
the same mRNA species [1]. However, in contrast to 
human, the intracdlular precursor for a r M / H I - 3 0  is 
encoded on two distinct mRNAs in the pig. 
Materials and Methods 
The Escherichia coli protein blocking extract, EXO 
III nuclease digestion kit, plasmid sequencing vector 
(pGEM-4Z), SP6 and T7 primers were all from Pro- 
mega Biotech (Madison, WI). All other reagents were of 
molecular biology grade and obtained from various 
commercial sources. 
Animals 
The tissues were collected from pregnant sows at 
days 6, 12, 29, 40, 45, 60, 90, 105 and 110 of gestation 
(term = day 115), frozen immediately in liquid nitrogen 
and stored at - 7 0  °C until use. The liver was removed 
from day 40, 90, 110 porcine fetuses and day 0 and 21 
neonates. Fetal intestine and stomach at 110 days were 
also removed. Animal use protocols were conducted 
under guidefines established by the American Veterinary 
Medical Association and the National Institutes of 
Health and v'ere previously approved by the Institu- 
tional I.ab~ratory Animal Care and Use Committee of 
The Ohio 5tare University. 
Screening of pig liver eDNA library 
(a) Immunoscreening. An adult pig liver eDNA library 
(Clontech; Palo Alto, CA) constructed in iambda gt l i  
expression vector [17] was screened [18] with a rabbit 
polyclonal anti-human IGF-I antiserum (UB286), pro- 
vided by Drs LE. Underwood and J.J. Van Wyk, 
Division of Pediatric Endocrinology, University of 
North Carolina, Chapel Hill, and the National Hormone 
and Pituitary Program. The dilution of antiserum used 
in the screening was emperically determined (1/5000 
dilutions of the original concentration). 
(b) Hybridization screening. This was performed by a 
modification of the established procedures [18] and as 
previously described [15]. The plasmid DNA was di- 
gested with EcoRl and the eDNA insert was gel puri- 
fied (see below). All eDNA probes were labeled with 
deoxyribonucleotide [32P]triphosphates by nick transla- 
tion or random-primer labeling with specific activities 
of (3-5)- 10 s cpm/lag DNA usually obtained. The probe 
was used at a concentration of (1-2)- 106 cpm/ml. Pre- 
and post-hybridization conditions have been described 
elsewhere [15]. 
Preparation of bacteriophage DNA 
Large-scale DNA preparation from the recombinant 
bacteriophages were carried out using the plate lysate 
method [18]. Small scale phage DNA preparation was 
performed b" DEAE cellulose (DE52) procedure as 
outlined below. Briefly, 1.5 ml of a phage lysate con- 
taining (5-10). 109 pfu/ml was mixed with an equal 
volume of DEAE cellulose (pH 6.7) and the mixture 
was inverted 20-30-times. Bacterial DNA and RNA 
were pelleted by centrifugation for 10 rain at 4°C, the 
supernatant containing the phage removed, DNA ex- 
tracted with phenol/chloroform after proteinase K 
treatment and precipitated in ethanol at - 2 0 ° C  for 
16-18 h. 1-3 /Lg of phage DNA was digested with 
EcoRl and electrophoresed on a 0.8~ agarose slab gel, 
for ethidium bromide staining or blot hybridization. 
Subcloning and probe purification 
Standard procedures were employed for subcloning 
eDNA clones [18]. eDNA probe purification and elu- 
tion from acrylamide gel have been previously described 
[15]. The 3' UT region specific probe (AT 125).was 
isolated from the 1.3 kb cDNA insert of sti.l.10 plasmid 
(see Fig. 1) by double digestion with Aval and EcoRI, 
followed by elution from the gel. 
RNA isolation, Northern and dot blot analysis 
Tissue RNA was prepared using the guanidine iso- 
thiocyanate procedure [18]. The RNA was denatured 
and fractionated on 1.2~ formaldehyde-agarose gels 
and transferred to a Biotrans membrane (Schleicher and 
Schuell, Keene, NH). Blot hybridization was carried out 
at 42°C [15]. RNA dot blotting was performed in the 
following manner. Samples containing known amounts 
of total cellular RNA were denatured in 20 mM Tris- 
HCI (pH 7.0), 507o (v/v) deionized formamide and 6~ 
(v/v) formaldehyde. They were heated to 65°C for 15 
min and an equal volume of 20 x SSC was added. The 
RNA was bound to a Biotrans membrane using a 
microsample filtration manifold (Schleicher and 
Schuell). Filters were washed with 20 × SSC, air dried 
and baked for 2 h at 80 ° C. The dot blot hybridization 
was performed in a r~pid hybridization buffer 
(Amersham, Arlington Heights, IL) following the 
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manufacturer's recommendation. RNA and dot blots 
were quantified by laser densitometer (LKB) scanning 
of autoradiograms. Values for a~-M/HI-30 signals from 
each time point were corrected by normalizing against 
serum albumin mRNA values in order to account for 
individual variation and RNA loading differences. 
DNA sequencing 
DNA restriction fragments were subcloned into 
pGEM-4Z sequencing vector. The cDNA inserts were 
sequenced in both orientations and on both strands 
using the Sanger dideoxy chain termination method 
[19], SP6 and T7 primers and Sequenase (United States 
Biochemicals). To sequence the largest cDNA, it was 
necessary to generate several Pstl and PstI,nfinus sub- 
clones in pGEM-4Z. We took advantage of Pstl sites 
present in the cDNA insert (Fig. 1A) and the linker 
region of pGEM-4Z. Plasmid DNA of the largest clone 
(sti.l.10) was digested with PstI followed by fractiona- 
tion of the product in a 5% PAGE gel (see above). The 
Pstl restricted fragments were then recovered and sub- 
cloned into pGEM-4Z for sequencing. In order to con- 
struct a Pstl-minus subclone, the gel slice containing 
the vector DNA and the remaining portion of the 
cDNA insert was recovered. The DNA fragment was 
similarly ehited from the gel slice, religated and used for 
transformation of E. coil competent cells. Portions of 
the sequence data were also compiled after the con- 
struction of unidirectional deletions with Exonuclease 
Ill strategy [20]. The sequence data were analyzed on an 
IBM XT computer with an aid of Microgenie program 
(Beckman Instruments, Palo Alto, CA). 
R ~  
Isolation and characterization of porcine a/-microglobu- 
iin / HI-30 and serum albumin cDNA clones 
Our initial goal was to isolate cDNA clones corre- 
sponding to porcine insulin-like growth factor I (IGF-I). 
Since porcine IGF-I immunoreacts with the rabbit anti- 
serum raised to human IGF-1 [21], we chose to employ 
this antiserum for isolation of IGF-I from a pig liver 
cDNA library. The antiserum (UB286) is specific for 
human IGF-I and exhibits less than 0.5% cross-reactiv- 
ity with insulin-like growth factor II and essentially no 
reaction with insulin. The liver was used as the starting 
tissue since it was known to be the major site of IGF-I 
synthesis in human [22]. Of 15 immunoreactive recom- 
binant bacteriophages initially identified by screening a 
total of 5.105 plaques, only one (CLT8c) remained 
antibody positive through several rounds of im- 
munoscreening. Digestion of CLTSc phage with EcoRI 
yielded three cDNA inserts of 719 (sti.3), 636 (sti.1) and 
456 (sti.2) basepairs (bp). Surprisingly, these cDNA 
inserts did not hybridize to a 32P-labeled porcine IGF-I 
cDNA probe and were negative in an epitope selection 
experiment (data not shown). 
To determine the identity of the eDNA inserts, they 
were subcloned into pGEM-4Z plasmid vector and se- 
quenced from both orientations using the dideoxy chain 
termination method [19]. A search of the gene data 
bank revealed extensive sequence homology between 
one of the inserts and the L-chain inhibitor of human 
laTl [1]. Subsequently, this cDNA clone (sti.1) was 
used to rescreen the liver library to obtain larger cDNA 
fragments. A number of hybridization positive bac- 
teriophages were obtained representing an al-micro- 
globulin/HI-30 (a~-M/HI-30) mRNA abundance of 
0.5% in pig liver cDNA libary. EcoRI.digested gel- 
fractionated phage DNA was then hybridized to the 
original isolate resulting in identification of two ad- 
ditional cDNA clones of approximately 1.0 kb (sti.l.4) 
and 1.3 kb (sti.l.10) which differed by the presence of 
196-nucleotide long 3' UT segment unique to sti.l.10. 
The two other cDNA clones (sti.2 and sti.3) were identi- 
fied after DNA sequence analysis and RNA blotting 
and found to correspond to porcine serum albumin 
(data not shown). Fig. 1C depicts the strategy used in 
sequencing these clones and their alignment with a 
cDNA recently reported for pig serum albumin [23l. 
The partial restriction map and sequencing strategy 
used in determining the complete nucleotide sequence 
of L-chain clones are depicted in Fig. 1A and B. ll~e 
largest cDNA fragment (sti.l.10) consisted of a 1008 bp 
open reading frame encoding 335 amino acids followed 
by an inframe TGA translation termination codon and 
a 295-nucleotide 3' UT region. By analogy to a human 
cDNA [1], the pig clone contained nucleotide sequences 
for 5' amino terminal signal peptide and complete 
sequence for a~-M/HI-30 mRNA and a large segment 
of 3' UT region. The sequence of the original clone 
(sti.1) was found to be identical to position 268-861 
and 514-1107 of the two others (sti.l.4 and sti.l.10), 
respectively. Sti.l.4 cDNA clone also contained identi- 
cal sequence to nucleotide 247-1107 of sti.l.10 but both 
sti.1 and sti.l.4 differed from sti.l.10 in three nude, o- 
tides, one of which (A -* G) was located at position 555 
in the coding sequence of sti.l.10. This nucleotide did 
not change the amino acid usage but generated an Aval 
restriction site in sti.l.10 (Fig. 2) which was absent from 
the two smaller cDNAs (Fig. 1A). The two other 
nucleotide differences (C ~ T and T - ,  C) were located 
in the 3' UT region of sti.l.10 at positions 1016 and 
1061, respectively. The putative polyadenylation signal 
AATAAA was located 70 nucleotides beyond the TGA 
and mapped to the same position in all three eDNA 
clones (Fig. 1A). In both sti.1 and sti.l.4 but not sti.l.10, 
this signal was followed by a poly(A) tract of varying 
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Fig. l. Restriction map and sequencing strategy for determining ai-M/HI-30 and serum albumin nucleotide sequences. (A) Restriction sites and 
the physical map of three independently isolated aI-M/HI-30 eDNA. The smallest eDNA (sti.t) was used to rescrcen the library for isolation of 
sti.l.4 and sti.l.10 clones. Ceding sequences are shown in solid and non-coding 3' untranslated (UT) regions are cross-hatched. The thin lines 
represent poly(A) tracts in sti.l and sti.l.4. Short thick vertical arrows below the 3' UTs indicate identical locations of polyadenylation signals. The 
translation termination codon TGA is marked by an asterisk and maps to the same position in all isolates. (B) Long arrows indicate the bilateral 
order and direction of various subclones used in DNA sequence analysis of a]-M/HI-30 mRNA. (C) The previously reported eDNA clone for 
porcine serum albumin is shown as an open box, with the 5' and 3' UT regions dotted. The thick lines below the published pig serum albumin 
eDNA [23] indicate the two EcoRI fragments isolated in this work. Sti.2 extends the previously reported eDNA by 104 nucleotide in the 3' 
direction. 
Evolutionary considerations 
The 5' amino terminus of sti.l.10 contained coding 
sequences for a 183 amino acid polypeptide known as 
at-microglobulin [24], or protein HC [6,9] in human, 
while the carboxy-terminus encoded two Kunitz pro- 
teinase inhibitory domains (HI-30) that constitute the 
L-chain of IaTI and PaTI [6,8]. The nucleotide and 
deduced amino acid sequences of this e D N A  (sti.l.10) 
have been presented in Fig. 2. The putative proteolytic 
cleavage site for release of at-microglobulin and HI-30; 
Arg Arg [1] occurs at amino acid residues 188 and 189 
of sti.l.10. Derived amino acid sequences of human and 
pig proteins encoded by a t - M / H I - 3 0  m R N A  exhibited 
80~ homology. Amino acid sequence of a r M  is de- 
picted in Fig. 3 along with those of human, rat, rabbit  
and the guinea-pig [25,26] to demonstrate  sequence 
conservation. Except for human and a partial sequence 
for rat a]-M, no other cDNAs  were available from 
other species thus partial amino acids for these peptides 
have been compared.  
HI-30 was isolated from human urine (syn UTI) [27] 
and shown to be identical to that found in serum [28]. 
Partial amino acid sequence for porcine homolog of 
HI-30 (Pl-30) has been characterized from plasma 
[29,30]. Our cDNA-der ived amino acid sequences dif- 
fered in nine positions (residues: 258, 269, 277, 282, 
Fig. 2. Nuclcotide and deduced amino acid sequences of porcine el-M/HI-30 mRNA. The nucleotide sequences are numbered above the lines and 
amino acids on the side. The reactive site of the two proteas¢ inhibitory domains l and ll (leucine and arginine, respectively) and the preceding 
three amino acids are boxed. The two arginines at the site of protcolytic cleavage are indicated by asterisks. The 19 amino acid long repeats 
flanking the reactive site in domain II are shown in bold type. Only 4 out of 19 amine acids are different in the repeats. The nuclcotide variations 
dcteeted between the three overlapping cDNAs are indicated directly above the variant nucleotides by the use of lower case letters. The new Avat 
site generated by A --* G substitution has been indicated. Putative N-linked glycosylation sites are overlined whereas the polyadenylation signal and 
EcoRi sites are underlined. The two potential poly(A) addition signals are shown by arrows. 
GTG AGC GCC AGC CCT GTG CTG ACA TTG 
Val Ser Ala Ser Pro Val Leu Thr Leu 
CTG TCT AGG ATC TAC GGG AAA TGG TTC 
Leu Ser Arg Ile Tyr Gly Lys Trp Phe 
AAG AGG TTC AAG GAC AAG ATG ATG ATG 
Lys Arg Phe Lys Asp Lys Met Met Met 
AGG GAG ATC AGC GTG ACC AAG ACT CAC 
Are GIu Ile Ser Val Thr Lys Thr His 
GCT TAT GAG AAA ACA AGC ACT GAT GGA 
Ala Tyr Glu Lys Thr Ser Thr Asp Gly 
w 
ACC ATG GAG TCC TAT GTG GTC CAC ACC 
Thr Met Glu Ser Tyr Val Val His Thr 
AAG TTC AGC CGC CGC CAT GGA CCA ACC 
Lys Phe Ser Arg Arg His Gly Pro Thr 
CTT CGG GAA AGC CTG CTG GAG GAG TTC 
Leu Arg Glu Ser Leu Leu Glu Glu Phe 
GAC TCC ATC TTT ACG ATG COC GAC AGA 
Asp Ser Ile Phe Thr Met Pro Asp Arg 
F A~, l 
CCC ACC CTA CTC TCG AGA GCC CGG CGG 
Pro Thr Leu Leu Ser Arg Ala Arg Arg 
GCT GGA CAA CCA GTA GCA GAT TTC AGC 
Ala Gly Gln Pro Val Ala Asp Phe Ser 
CAAIGGC CCT TGC CTG'IGGC ATG ATC AAG 
Gln~GlY Pro Cys LeulGly Met Ile Lys 
GAG ACC TTC CAC TAT GGT GGC TGC ATG 
GIu Thr Phe His Tyr Gly Gly Cys Met 
TGT CTG CAG ACC TGC CGG ACT GTG GAG 
Cys Leu Gln Thr Cys Arg Thr Val Glu 
A•r• GGT TTT TTC CAG CTC TGG GCG TTT Gly Phe Phe Gln Leu Trp Ala Phe 
TAT GGG GGC TGC CAG GGC AAC GGC AAC 
Tyr Gly Gly Cys Gln Gly Asn Oly Asn 
TGC GGC GTC CCC GGT GAA GAG GAT GAA 
Cys Gly Val Pro Gly Glu Glu Asp Glu 
GAATTCCG 
30 60 
CCC AAT GAC ATC CAG GTG CAG GAG AAC TTC GAC 
Pro Asn Asp Ile Gln Val Gin Glu Asn Phe Asp 20 
90 120 
CAC GTG GCC GTG GGC TCC ACC TGC CCC TGG CTG 
His Val A1a Val Gly Set Thr Cys Pro Trp Leu 40 
150 180 
GGC ACG CTG ATG CTG GGA GAG GGG GCG ACG GAG 
Gly Thr Leu Met Leu G1y G1u Gly Ala Thr Glu 60 
210 240 
CGG AGG A~% GGT ATC TGT GAG GTG ATC TCT GGG 
Arg Arg Lys G1y Ile Cys Glu Val Ile Ser Gly 80 
270 300 
AAG TTC CTC TAT CAC AAA TCC AAA TGG AAC ATC 
Lys Phe Leu Tyr His Lys Ser Lys Trp Ash Ile 100 
330 360 
AAC TAT GAT GAG TAT GCC ATA TTT CTG ACC AAG 
Ash Tyr Asp G1u Tyr Ala Ile Phe Leu Thr Lysl20 
390 420 
CTT ACT GCC AAG CTC TAC GGA CGG GAG CCG CAG 
Leu Thr Ala Lys Leu Tyr Gly Arg Glu Pro Gln 140 
450 480 
AGG GAG GTT GCC CTG GGC GTG GGC ATC CCG GAG 
Arg Glu Val A1a Leu Gly Val Gly Ile Pro Glu160 
51~ 540 
GGA GAG TGT GTC CCT GGG GAG CAG GAG CCT GAG 
Gly Glu Cys Val Pro Gly Glu Gin Glu Pro Glu180 
57O 600 
GCC GTG CTG CCC CAG GAA GAG CaA GGA TCA GGA 
Ala Val Leu Pro Gin Glu Glu Glu G1y Ser Gly200 
630 660 
AAG "AAA GAA GAT TCC TGC CAG CTG GGC TAC TCC 
Lys Lys GIu Asp Set Cys Gln Leu Gly Tyr Set220 
690 720 
AGG TAT TTC TAT AAT GGC TCA TCC ATG GCC TGC 
Arg Tyr Phe Tyr Asn G1y Ser Set Met Ala Cys240 
750 780 
GGG AAC GGC ~AT R~%C TTC GTC TOG GAG A~G GAG 
Gly Asn GIy Asn ~sn Phe Val Set Glu Lys Glu 
810 840 
GCC TGC AGT CTC CCC ATC GTC TCCIGGC CCC TGC 
Ala Cys Ser Leu Pro I1e Val SerlGly Pro Cys 
870 900 
GAT GCC GTG CAG GGG AAG TGT GTT CTC 'JL~C AA%C 
Asp Ala Val Gln Gly Lys Cys Val Leu Phe Asa 
930 960 
OAG TTC TAC TOG GAG AAG GAG TGO AAA GAG TAC 
Oln Phe Tyr Ser Olu Lys Olu L~s Lys Glu Tyr 
990 c 
GAG CTG CTG CGC TCC TCC AAC TGA CCAGTCCGCAG 












284, 285, 292, 310 and 314; Fig. 2) from the amino acid 
sequence of Pl-30 [30]. 
Pregnancy-associated and developmental expression of ai- 
M / HI-30 mRNA 
Northern  blot analysis of total  R N A  from pig liver 
probed with 32P-labeled serum albumin c D N A  detected 
a single m R N A  of approx. 2.5 kb as shown in Fig. 4, 
Fig. 5A and B. This e D N A  was subsequently used in 
Northern  blot hybridizat ion as a control  for R N A  load- 
ing differences. To study temporal  expression of a t- 
M / H I - 3 0  m R N A  in pregnant  animals, total  R N A  from 
sows was hybridized to the 32p-labeled c D N A  probes 
for a t - M / H I - 3 0  and  serum albumin.  The  results, shown 
as a bar  graph in Fig. 4, demonst ra ted  that  pig a t- 
M / H I - 3 0  m R N A  levels remained virtually unchanged 
during pregnancy. Interestingly, also no  st imulat ion of 
a i - M / H I - 3 0  m R N A  expression was observed in estro- 
gen-primed animals (E 2, Fig. 6). To delineate develop- 
mental  expression of this mRNA,  total liver R N A  from 
fetal and pos tpar tum pigs was analyzed by R N A  blot- 
ting. The results shown in Fig. 5A and  5B revealed that  
L-chain m R N A  expression was considerably higher in 
2 5  
pig V S A S P V L T L P N D I  Q V Q E N F D L S R I  Y 
human - - - G P - P - P - D N . . . . . . .  N I S - I - 
rat S N - P - L- D Z . . . .  X - - N A A 
r a b b i t  S P - P - L - D D . . . . . . .  E L S - I - 
g u i n e a  p .  L - D D . . . . . . .  D E S - M - 
5 0  
pig G K W F H V A  VG S T C PW LK R F K D K M M  M G  
human - - W Y N L - I . . . . . . . .  K I M - R - T V S 
rat 
rabbit - - X Y N L - V 
guinea p. - - L ¥ S L - I - - - 
75 
pig T L M L G E G A T E R E I S V T K T H R R K G I C  
human - - V . . . . . . .  A - - - M - S - R W - - - V - 
I00 
pig EV I S G A Y  E K T S T D G K F L Y H K S K W N  I 
human - E T . . . . . . .  D . . . . . . . . . . . . . .  
125 
pig T M E S Y V V H T N Y D E Y A I  F L T K K F S R R  
human . . . . . . . . . . . . . . . . . . . . . . . .  H 
150 
pig HG PT L T A K L Y G R E  PQ L R E S  L L E E F R  
human - G - - I . . . . . . .  A . . . .  E T - - Q D - - 
rat - A - - I . . . . . . .  E . . . .  DS - - Q E - - 
175 
pig E V A L G V G  I P E D S  I F T M P D R G E C V P G  
human V - - Q G . . . . .  D - - F T - A . . . . . . . .  
rat E - -  LS . . . . .  N - -  V F - A  . . . . . . . .  
188 
pig EQ E P E PT L LS RA R 
human E Q - P - - I - I P - V - 
rat D R - V - 
Fig. 3, Inter-species comparison for porcine a~-microglobulin. Pig, 
human and rat amino acids are derived from cDNA sequences whereas 
that of rabbit and guinea-pig are based on amino terminal peptide 
sequence analysis. The presence of a dash (-) denowes sequence ho- 
mology. Blank spaces indicate where no published sequence were 
available, (x) where the amino acid residue was not determined and 
(z) where a deletion has been made for maximum homology. The data 
for the human cDNA are taken from Ref. 1; for rat from positions 4 
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Fig. 4. Pregnancy-associated aI-M/HI-30 mRNA expression. Total 
RNA was prepared from pregnant animals at indicated time points. 
RNA blots were prepared and probed with a,-M/HI-30 and serum 
albumin-specific riP-labeled cDNAs as indicated. The two bands 
representing aI-M/HI-30 mRNA are located below 18 S ribosomal 
RNA marker, whereas the single mRNA band between the 18$ and 
28S belongs to serum albumin (cf Fig. 5). The bar charts are obtained 
by densitometer scanning of autoradiograms (see RNA isolation, 
"Materials and Methods'). * Term in the pig is 115 days. 
fetal and  neonata l  liver and  declined to low levels in 
pregnant  adul t  pigs. Densi tometr ic  scanning of  blots  
from two independen t  exper iments  indicated 5 -8- fo ld  
higher levels of  expression in fetal liver compared  to 
that  of acult  pigs (see bar  graphs  in Fig. 5A and  B). 
The a t - M / H I - 3 0  c D N A  probe  used in blot  hybridi-  
zat ion identified two m R N A  bands  corresponding to an  
est imated size of 1.3 kb  and  1.6 kb  (Fig. 4 and  5A). The  
size of the two m R N A s  remained cons tan t  dur ing  preg- 
nancy and  deve lopment  and  no  changes  in their  relative 
abundance  were observed. Previous reports  have not  
indicated the presence of two h u m a n  a t - M / H I - 3 0  
mRNAs .  Therefore,  to character ize the two var iant  
m R N A s  we constructed a e D N A  probe  specific for the 
3'  U T  of sti . l .10, the longest e D N A  in our  clones. This 
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Fig. 5. Temporal regulation of ai-M/HI-30 mRNA in pig liver. Total pig liver RNA (40 pg) was analyzed by RNA blotting. Hybridizat~,,n probes 
were: (A) 32P-labeled al-M/HI-30 cDNA or (B) 32 P-laheled AT 125 (see 'Results'). Both blots were also hybridized w/th the serum albunfir, cDNA 
probe as the reference gene (see legend to Fig. 4 and text). Liver RNA was obtained from individual animals at the development stages indicated. 
The two RNA blots were replicas prepared from the .same RNA but hybridized separately. Bar charts are explained in legend to Fig. 4. 
was achieved as described in 'Materials and Methods' 
(see also Fig. 1A), yielding a 125-nucleotide cDNA 
fragment (AT 125). This diagnostic probe hybridized 
only to a single mRNA of approx. 1.6 kb with no 
hybridization to the 1.3 kb mRNA even after prolonged 
autoradiographic exposure (Fig. 5B), indicating that the 
1.3 kb cDNA (sti.l.10) was derived from 1.6 kb mRNA, 
whereas the other two at-M/HI-30 cDNAs (sti.1 and 
sti.l.4) originated from 1.3 kb mRNA. Using RNA dot 
blot analysis, liver was shown to be the major site of 
porcine am-M/HI-30 mRNA synthesis with lower levels 
observed in the stomach (Fig. 6). Few or no signals were 
detected for mammary, spleen and uterus at various 
developmental stages. Similar findings were also ob- 
tained by Northern blot analysis (not shown). 
Discussion 
We have identified three cDNA fragments corre- 
sponding to pig a r M / H I - 3 0  and serum albumin 
mRNAs (sti.1, sti.2 and sti.3) all contained within a 
single immunoreactivc bacteriophage (CLTSc). Cross- 
reactivity of CLTSc with the antiserum raised to human 
IGF-I may have been due to shared epitopes between 
pig serum albumin and/or  at-M/HI-30 with human 
IGF-I, or to impurities present in antiserum prepara- 
tions. However, the former possibility is unlikely as 
these proteins are unrelated both functionally and 
structurally, based on amino acid sequence c o m p ~  
and hydropathicity analyses (data not shown). It is also 
likely that high serum concentration of laTl  protein 
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Fig. 6. Tissue distribution of laT!  messenger RNA. Total RNA was 
prepared from either fetal or maternal pig tissues at various stages of 
development and denatured with formaldehyde. The RNA was ap- 
plied in 5, 10 and 20 pg quantities to Biotrans membrane and 
hybridized to a 32p-labeled cDNA probe. Sample RNA blotted onto 
each well was adjusted to a total of 20/zg. composed of the liver tissue 
RNA at the given concentration plus yeast tRNA as a carrier. The dot 
blot was later hybridized to ribosomal DNA probes (not shown) to 
verify equal RNA loading. Control, yeast tRNA, D, day; E 2, pseudo- 
pregnant: 1, intestine; L, liver; M, mammary; Sp, spleen; St. stomach 
and U, uterus. 
(0.5 mg/ml) [28] which is also consistent with high 
mRNA representation (0.5% in lambda gtl l  expression 
library) was responsible for production of cross-reacting 
anti-IaT! L-chain antibody in IGF-1 antiserum pre- 
parations. This antiserum could have subsequently re- 
acted to the recombinant phage expressing a t -M/Hl-  
30/jS-galactosidas¢ fusion protein during our library 
screening. We did not investigate whether physical as- 
sociation of at-M and immunoglobulin A [10] played a 
role in these events. Presence of two unrelated cDNAs 
encoding serum albumin and the L-chain of laTl was 
also likely to have been due to a recombination event 
and an artefact during library construction. It is not 
uncommon for highly abundant mRNA species to be 
~igated together and cloned into the same lambda phage. 
As this work was in progress a cDNA clone was 
described for porcine serum albumin, the sequence of 
which [23] was identical to those we isolated (data not 
shown). We detected a single mRNA species of approx. 
2.5 kb consistent with the size of mature serum albumin 
mRNA in other species [31]. The at-M/HI-30 cDNA 
sequence described here identifies the pig as only the 
second species for which the DNA sequence is now 
available. Like its human homolog [1,14], the porcine 
cDNA also encodes the HI-30 [30] and al-M [6]. How- 
ever, in pig at-M/HI-30 appears to be encoded by at 
least two variant mRNAs. Therefore, we conclude that 
these mRNAs are either the result of different poly- 
adenylation or represent unprocessed nuclear RNA. 
Three single point variations were detected in sti.l.10, 
one of which (position 555) may represent a restriction 
fragment length polymorphism (RFLP) since it intro- 
duced a new Aval site into the domain encoding a~-M 
without changing the amino acid usage. The presence of 
these single-base substitutions may indicate allelic dif- 
ferences in a i -M/HI-30 gene. although it is possible 
that they were generated during the cDNA library con- 
struction. RFLP's in a , -M/HI-30 gene have been previ- 
ously documented [32], though not involving the 
nucleotides reported here. Overall, there was 80% se- 
quence conservation between deduced amino acids of 
pig am-M/HI-30 mRNA and its human counterpart. 
Homology appears to vary when different domains are 
compared; pig at-M shows 79~$ homology to human [1], 
78%, 77~ and 68% with partially reported domains of 
rat, rabbit and guinea-pig, respectively [25,26]. Human 
a r M  has been shown to contain tripeptide Asn-x- 
Ser/Thr at residues 20-22 [26], the consensus sequence 
for N-linked glycosylation [33]. Our cDNA assigns Asp- 
Lys-Ser to these positions thus excluding the possibility 
of glycosylation at this site, similar to rat, rabbit and 
guinea-pig [26]. How.Je :  the nucleotide sequence de- 
scribed here confirms the presence of a second N-linked 
glycosylation at positions 99-101 similar to that re- 
ported for human [1,26]. With respect to the proteinase 
inhibitory domains (comparison is not shown), porcine 
polypeptide is 85% homologous with sheep [34], 83~ 
with human and bovine [1,29] and 81% with the horse 
inhibitor [30]. It is noteworthy that the deduced amino 
acid sequence of L-chain (HI-30) in our cDNA and that 
obtained by amino acid sequencing of the pig [30] are in 
major agreement (93% homology). 
The light and heavy chain(s) in laTI  and PaTI are 
cross-linked by a chondroitin sulfate-like carbohydrate 
structure [35], reported to be glycosaminoglyeans 
(GAGs) [36]. The GAG-like structure is believed to be 
originated from serine-10 of human HI-30 [8]. We also 
note that the amino acids flanking the serine-10 (re- 
sidues 198-201 in Fig. 2) in pig ai-M/HI-30 are identi- 
cal to human sequence except for an alanine to glycine 
substitution indicating that similar carbohydrate struc- 
tures may be present in porcine HI-30. Taken together, 
these findings imply that IaTI L-chain gene has re- 
mained relatively conserved throughout evolution. Re- 
cently, it was shown that the two tandem domains of 
HI-30 were each encoded by a single exon that was not 
split by iatervening sequences [37] resembling aprotinin 
gene organization to whose family HI-30 belongs. We 
have also noted the presence of two repeat sequences in 
the two proteinase inhibitory domains which may indi- 
cate a gene duplication event involving a single exon. 
We previously demonstrated that uterine but not 
liver IGF-I mRNA levels underwent drastic changes 
during pregnancy [15]. Feeding of colostrum devoid of 
proteinase inhibitors results in decreased intestinal ab- 
sorption in vivo of albumin, lgG, /]-lactoglobulin and 
growth factors in the neonatal pig [38,39]. Moreover, 
HI-30 is present in mammary secretions along with 
trypsin and chymotrypsin, suggesting a role for this 
55 
inhibitor during lactation [40]. However, little is known 
regarding modulation of laTl L-chain gene expression 
and contribution of this inhibitor to colostrum-derived 
prot¢inase inhibitory pool in pregnant sows. Examina- 
tion of uterus and mammary tissues of sows at various 
stages of pregnancy did not detect a significant dif- 
ference in steady state laTl L-chain mRNA levels, 
similar to timings for anther rat liver specific gene(s) 
encoding al-inhibitor I11 [41]. Our data also indicates 
that hepatic regulation of laTI light chain mRNA in 
the pig unlike rat a2-macroglobulin protease inhibitor 
[42] is not influenced by pregnancy. We also studied 
developmental expression of at-M/HI-30 mRNA at 
five different ages. Quatitative analysis of hybridization 
signals by a laser densitometer indicated that a~-M/Hl- 
30 mRNA levels were 5-8-fold higher in the fetus and 
neonate than adult animal. Analysis of two different 
RNA preparations and the use of Y-UT-specific probe 
confirmed the general pattern of age dependence in 
L-chain mRNA expression. Decreased levels of pro- 
teinase inhibitory capacity in adult pigs compared to 
fetal tissues have been reported elsewhere [43] verifying 
the RNA expression studies reported here. Charac- 
terization of porcine at-M/HI-30 cDNA sequence and 
its mRNA expression reveals evolutionarily conserved 
nature of these genes but indicates specific differences 
in pattern of gene expression. These findings should 
help accelerate efforts to understqad the role of these 
important family of inhibitors 
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